Jeffrey Cole
Geschäftsführer bei CADRENAL THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Profil
Jeffrey S.
Cole is the founder of Espero Pharmaceuticals, Inc. He is currently the Chief Operating Officer at Cadrenal Therapeutics, Inc. since 2024.
Previously, he served as the Chief Financial Officer at Legacy Pharmaceuticals International GmbH from 2008 to 2010.
Mr. Cole completed his undergraduate degree at the University of Southern California and holds an MBA from the University of Michigan.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.04.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Jeffrey Cole
| Unternehmen | Position | Beginn |
|---|---|---|
| CADRENAL THERAPEUTICS, INC. | Geschäftsführer | 08.02.2024 |
Ehemalige bekannte Positionen von Jeffrey Cole
| Unternehmen | Position | Ende |
|---|---|---|
Legacy Pharmaceuticals International GmbH
 Legacy Pharmaceuticals International GmbH Financial ConglomeratesFinance Part of Legacy Pharmaceuticals International LLC, Legacy Pharmaceuticals International GmbH is a Swiss investment company with an interest in pharmaceutical companies. The company is based in Birsfelden, Switzerland. | Finanzdirektor/CFO | 01.08.2010 |
Espero Pharmaceuticals, Inc.
 Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Espero Pharmaceuticals, Inc. is a pharmaceutical company that specializes in developing therapeutics for unmet needs in thrombosis and cardiac rhythm control. Espero Pharmaceuticals is based in Jacksonville, FL and has subsidiaries in the United States. The private company's portfolio includes tecarfarin, which is used for patients requiring anticoagulation, and a novel candidate for treating arrhythmias. The company was founded by Jeffrey S. Cole and Quang X. Pham. | Gründer | - |
Ausbildung von Jeffrey Cole
| University of Southern California | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CADRENAL THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Legacy Pharmaceuticals International GmbH
Legacy Pharmaceuticals International GmbH Financial ConglomeratesFinance Part of Legacy Pharmaceuticals International LLC, Legacy Pharmaceuticals International GmbH is a Swiss investment company with an interest in pharmaceutical companies. The company is based in Birsfelden, Switzerland. | Finance |
Espero Pharmaceuticals, Inc.
Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Espero Pharmaceuticals, Inc. is a pharmaceutical company that specializes in developing therapeutics for unmet needs in thrombosis and cardiac rhythm control. Espero Pharmaceuticals is based in Jacksonville, FL and has subsidiaries in the United States. The private company's portfolio includes tecarfarin, which is used for patients requiring anticoagulation, and a novel candidate for treating arrhythmias. The company was founded by Jeffrey S. Cole and Quang X. Pham. | Distribution Services |
